Patient hydration system with taper down feature

Details Patient hydration system with taper down feature Patient hydration system with taper down feature

2008-05-20

2010-06-01

Sirmons, Kevin C (Department: 3767)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S067000, C604S031000

Reexamination Certificate

active

07727222

ABSTRACT:
A patient hydration system with an infusion subsystem which infuses fluid into a patient and a urine output measurement subsystem for measuring the amount of urine output by the patient. A controller is configured to control the infusion subsystem and is responsive to the urine output measurement subsystem. The controller includes a balancing function which controls the infusion subsystem to administer fluid infused into the patient to balance the urine output with the fluid infusion. The controller also includes a taper down function which controls the infusion subsystem to administer fluid infused into the patient at a rate less than the rate of urine output by the patient.

REFERENCES:
patent: 3954010 (1976-05-01), Hilblom
patent: 4132644 (1979-01-01), Kolberg
patent: 4146029 (1979-03-01), Ellinwood, Jr.
patent: 4204957 (1980-05-01), Weickhardt
patent: 4216462 (1980-08-01), McGrath et al.
patent: 4229299 (1980-10-01), Savitz et al.
patent: 4261360 (1981-04-01), Perez
patent: 4275726 (1981-06-01), Schael
patent: 4291692 (1981-09-01), Bowman et al.
patent: 4343316 (1982-08-01), Jespersen
patent: 4448207 (1984-05-01), Parrish
patent: 4449538 (1984-05-01), Corbitt et al.
patent: 4504263 (1985-03-01), Steuer et al.
patent: 4658834 (1987-04-01), Blankenship et al.
patent: 4712567 (1987-12-01), Gille et al.
patent: 4728433 (1988-03-01), Buck et al.
patent: 4813925 (1989-03-01), Anderson, Jr. et al.
patent: 4923598 (1990-05-01), Schal
patent: 4994026 (1991-02-01), Fecondini
patent: 5098379 (1992-03-01), Conway et al.
patent: 5176148 (1993-01-01), Wiest et al.
patent: 5207642 (1993-05-01), Orkin et al.
patent: 5722947 (1998-03-01), Jeppsson et al.
patent: 5769087 (1998-06-01), Westphal et al.
patent: 5814009 (1998-09-01), Wheatman
patent: 5891051 (1999-04-01), Han et al.
patent: 5910252 (1999-06-01), Truitt et al.
patent: 5916153 (1999-06-01), Rhea, Jr. et al.
patent: 5916195 (1999-06-01), Eshel et al.
patent: 5981051 (1999-11-01), Motegi et al.
patent: 6010454 (2000-01-01), Arieff et al.
patent: 6171253 (2001-01-01), Bullister et al.
patent: 6231551 (2001-05-01), Barbut
patent: 6272930 (2001-08-01), Crozafon et al.
patent: 6514226 (2003-02-01), Levin et al.
patent: 6531551 (2003-03-01), Ohno et al.
patent: 6537244 (2003-03-01), Paukovits et al.
patent: 6554791 (2003-04-01), Cartledge et al.
patent: 6640649 (2003-11-01), Paz et al.
patent: 6740072 (2004-05-01), Starkweather et al.
patent: 6752779 (2004-06-01), Paukovits et al.
patent: 6796960 (2004-09-01), Cioanta et al.
patent: 6827702 (2004-12-01), Lebel et al.
patent: 6942637 (2005-09-01), Cartledge et al.
patent: 7029456 (2006-04-01), Ware et al.
patent: 7044022 (2006-05-01), Ericson et al.
patent: 7137964 (2006-11-01), Flaherty
patent: 7278983 (2007-10-01), Ireland et al.
patent: 2002/0072647 (2002-06-01), Schock et al.
patent: 2002/0107536 (2002-08-01), Hussein
patent: 2002/0151834 (2002-10-01), Utterberg
patent: 2002/0161314 (2002-10-01), Sarajarvi
patent: 2003/0048185 (2003-03-01), Citrenbaum et al.
patent: 2003/0048432 (2003-03-01), Jeng et al.
patent: 2003/0114786 (2003-06-01), Hiller et al.
patent: 2004/0025597 (2004-02-01), Ericson et al.
patent: 2004/0059295 (2004-03-01), Cartledge et al.
patent: 2004/0081585 (2004-04-01), Reid
patent: 2004/0087894 (2004-05-01), Shahmirian et al.
patent: 2004/0122353 (2004-06-01), Shahmirian et al.
patent: 2004/0163655 (2004-08-01), Gelfand et al.
patent: 2004/0167415 (2004-08-01), Gelfand et al.
patent: 2004/0167464 (2004-08-01), Ireland et al.
patent: 2004/0176703 (2004-09-01), Christensen et al.
patent: 2004/0193328 (2004-09-01), Zaitsu et al.
patent: 2004/0243075 (2004-12-01), Harvie
patent: 2005/0027254 (2005-02-01), Vasko
patent: 2005/0065464 (2005-03-01), Talbot et al.
patent: 2006/0052764 (2006-03-01), Gelfand et al.
patent: 2006/0064053 (2006-03-01), Bollish et al.
patent: 2006/0184084 (2006-08-01), Ware et al.
patent: 2006/0235353 (2006-10-01), Gelfand et al.
patent: 2006/0253064 (2006-11-01), Gelfand et al.
patent: 2006/0270971 (2006-11-01), Gelfand et al.
patent: 2007/0088333 (2007-04-01), Levin et al.
patent: 2008/0027409 (2008-01-01), Rudko et al.
patent: 2008/0033394 (2008-02-01), Gelfand et al.
patent: 0258690 (1988-03-01), None
patent: WO 2006/041496 (2006-04-01), None
Written Opinion of the International Searching Authority for PCT Application No. PCT/US 09/02739 mailed Jun. 19, 2009 (four (4) pages).
U.S. Appl. No. 11/580,354, Rudko et al.
Rosamilia et al.,Electromotive Drug Administration of Lidocaine and Dexamethasone Followed By Cystodistension in Women With Interstitial Cystitis, International Urogynecological Journal Pelvic Floor Dysfunction 1997; 8(3): 142-5.
James M. Gloor and Vincente E. Torres,Reflux and Obstructive Nephropathy, Atlas of Diseases of the Kidney, on-line edition, vol. Two, Section I, Ch. 8, pp. 8.1-8.25 (date unknown).
Weinstein et al., “Potential Deleterious Effect of Furosemide in Radiocontrast Nephropathy,” Nephron 1992; 62: 413-415.
Lelarge et al., “Acute Unilateral Renal Failure and Contralateral Ureteral Obstruction,” American Journal of Kidney Diseases, vol. XX, No. 3, Sep. 1992, pp. 286-288.
Doty et al.,“Effect of Increased Renal Venous Pressure on Renal Function,” Journal of Trauma: Injury, Infection and Critical Care, vol. 47, No. 6, Dec. 1999, pp. 1000-1003.
Edelson et al., “Pharmacokinetics of Iohexol, a New Nonionic Radiocontrast Agent, in Humans,” Journal of Pharmaceutical Sciences, vol. 73, No. 7, Jul. 1984, pp. 993-995.
Hvistendahl et al., “Renal Hemodynamic Response to Gradated Ureter Obstruction in the Pig,” Nephron 1996; 74, pp. 168-174.
Pedersen et al., “Renal Water and Sodium Handling During Gradated Unilateral Ureter Obstruction,” Scand J Urol Nephrol 2002; 36, pp. 163-172.
Brezis et al., “Hypoxia of the Renal Medulla—its Implications for Disease” New England Journal of Medicine, vol. 322, No. 10, Mar. 9, 1995 pp. 647-655.
Heyman et al., “Pathophysiology Of Radiocontrast Nephropathy: A Role For Medullary Hypoxia,” Investigative Radiology, vol. 34, No. 11, Nov. 1999, pp. 685-691.
Urexact ® 2000 System, mhtml:file://C:\Documents%20and%20Settings\bob\Local%20Settings\Temporary%20Int...(3 pages).
Bard Lubricath 3-Way Catheters, http://www.bardmedical.com/urology/cathtour/3way.html (1 page).
Foley Catheter Introduction, Foley Catheter, http://www.emedicinehealth.com/articles/11633-1.asp; http://www.emedicinehealth.com/articles/11633-8.asp (2 pages).
Gambro Acute Renal Failure, Prisma Machine, http://www.gambro.com/Page.asp?id=2446; http://www.gambro.com/upload/press—media—toolkit/download—images/Prisma.jpg (2 pages).
Angiometrix, The Metricath System, http://www.angiometrx.com/Metricath%20System.htm (1 page).
Merit Medical Systems, Inc. 2003 Annual Report; Balloon Inflation Devices & Pressure Monitoring Syringes; Transducers and Accessories, http://www.corporatewindow.com/annuals/mmsi03/10kpage5.html (3 pages).
Cardiovascular Mikro-Tip Pressure Transducer Catheters, http://www.millarinstruments.com/products/cardio/cardio—sngldual.html (5 pages).
Infusion Dynamics The Power Infuser, http://www.infusiondynamics.com/powerinfuser/ (2 pages).
Ultra-Low Profile Single Point Load Cell—S215, http://smdsensors.com/detail—pgs/s215.htm (2 pages).
Rihal et al.,Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention, Circulation, May 14, 2002, pp. 2259-2264.
Solomon et al.,Effects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast Agents, The New England Journal of Medicine, vol. 331:1416-1420, Nov. 24, 1994 No. 21 (11 pages).
Wakelkamp et al.,The influence of drug input rate on the development of tolerance to furosemide, Br. J. Clin. Pharmacol 1998; 46, pp. 479-287.
Stevens, MD et al.,A Prospective Randomized Trial of Prevention Measures in Patients at High Risk for Contrast Nephropathy, Journal of the American College of Cardiology, vol. 33, No. 2, 1999, Feb. 1999, pp. 403-411.
Off

Affiliated with

Also associated with

Rating

Patient hydration system with taper down feature does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Patient hydration system with taper down feature, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Patient hydration system with taper down feature will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4156008